Soleno Therapeutics Inc SLNO 深 滬
已收盤 04-02 16:00:00 美东时间
39.49
+2.500
+6.76%
華盛通- 最 高40.08
- 今 開36.25
- 成交量 357.50万股
- 最 低 36.00
- 昨 收 36.99
- 總市值 20.39亿
- 52周最高 90.3199
- 市盈率 靜 101.02
- 換手率 6.92%
- 52周最低 29.43
- 委 比 -96.28%
- 總股本 5162.44万
- 歷史最高 90.3199
- 量 比 1.64
- 振 幅 11.03%
- 歷史最低 1.81
- 每 手 1
- 風險率 16.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | 药企并购潮来袭！Apellis制药飙升138%，获生化基因公司高额溢价收购；CNTA周涨38%
药企并购潮来袭！Apellis制药飙升138%，获高额溢价收购；SpaceX已递交上市申请！FLY周涨38%，公司为NASA新一代登月火箭供应商；CNTA周涨38%，公司获礼来收购>>
今天 11:11
新浪财经ESG：Soleno Therapeutics Inc. MSCI（明晟）ESG评级调降至CCC
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:31
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Soleno Therapeutics faces securities class action over DCCR safety disclosures
Soleno Therapeutics faces securities class action over DCCR safety disclosures Investors filed a securities class action against Soleno and certain senior executives in the U.S. District Court for the Northern District of California, captioned City of Pontiac Police and Fire Retirement System v. Sol
03-16 21:45
Soleno Therapeutics adopts amended and restated bylaws effective March 16, 2026
Soleno Therapeutics adopts amended and restated bylaws effective March 16, 2026 Soleno said its board approved and adopted amended and restated bylaws, effective March 16, 2026. The changes update advance notice provisions for stockholder proposals and director nominations. The amendments also refle
03-16 21:29
Soleno Therapeutics, Inc. (SLNO) Securities Fraud Class Action Lawsuit Filed; May 5, 2026, Lead Plaintiff Deadline
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025? Affected Soleno Therapeutics, Inc. Investor Summary Who: Soleno Therapeutics, Inc. (NASDAQ: SLNO) What: Securities...
03-15 05:46
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
TD Cowen Maintains Buy on Soleno Therapeutics, Lowers Price Target to $85
TD Cowen analyst Tyler Van Buren maintains Soleno Therapeutics (NASDAQ:SLNO) with a Buy and lowers the price target from $120 to $85.
02-27 02:32
